Most differentially methylated probes had an intermediate methylation level in IDH WT AML patients which was increased by approximately 20% in mIDH patients and this increase was highly significant (Fig. 1D; P<0.0001). This evidence concerns the gene IDH1 and acute myeloid leukemia.